Health & Biotech
ASX Health Stocks: Nova Eye surges over 40pc after USA Medicare changes withdrawn
ASX Health Stocks: More positive data for Recce’s drug, Cynata expects trial results in Q1
Check Up: The reason people quit weight-loss drugs
ASX biotechs with big catalysts in 2024: Part 2
ASX Health Stocks: Opthea up 13pc on $85m funding from giant investment firm Carlyle, new investor
Stock Insiders: Optiscan is expanding and the potential is enormous
Part 1: ASX biotechs with catalysts looking to pop in 2024
ASX Health Stocks: Next Science jumps almost 10pc after XPERIENCE study published in science journal
Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust
ScoPo’s Powerplays: ASX healthcare rises in Christmas rally as EBOS ups stake in Transmedic
ASX Health Stocks: UBI’s sales to exceed $1m, Pacific Smiles rejects takeover offer
Weed Week: Cannabis stocks down almost 20pc in 2023, but here’s why they could rebound by Q2 2024
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Santa (and ATO) delivers PharmAust $550k cash boost for Christmas
ASX Health Stocks: Neuren to start Phase 2 trial soon; Proteomics expands footprint in South America
FDA submission looms as Artrya’s AI platform aims to capture the huge cardio diseases market
Neurotech completes recruitment in Phase 2/3 autism spectrum disorder trial
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.